Loading fund information
Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
The fund’s disclosed portfolio, not an index membership list. Showing the largest 25 of 33 positions. The ten largest identified positions carry 53.6% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | — | United States | 7.92% | $37.42M |
| 2 | Abbott Laboratories ABT | Healthcare | United States | 5.67% | $26.77M |
| 3 | AbbVie Inc. ABBV | Healthcare | United States | 5.47% | $25.85M |
| 4 | Amgen Inc. AMGN | Healthcare | United States | 5.33% | $25.17M |
| 5 | Johnson & Johnson JNJ | Healthcare | United States | 5.17% | $24.44M |
| 6 | Merck & Co., Inc. MRK | Healthcare | United States | 5.05% | $23.87M |
| 7 | Eli Lilly and Co. LLY |
Source: SEC filings. Information and analytics, not investment advice.
| Healthcare |
| United States |
| 5.01% |
| $23.69M |
| 8 | Corcept Therapeutics Inc. CORT | Healthcare | United States | 4.96% | $23.42M |
| 9 | Gilead Sciences, Inc. GILD | Healthcare | United States | 4.52% | $21.37M |
| 10 | Pfizer Inc. PFE | Healthcare | United States | 4.49% | $21.24M |
| 11 | Amneal Pharmaceuticals, Inc. AMRX | Healthcare | United States | 3.74% | $17.68M |
| 12 | Invesco Private Government Fund | — | United States | 3.73% | $17.62M |
| 13 | Liquidia Corp. LQDA | Healthcare | United States | 3.66% | $17.28M |
| 14 | Travere Therapeutics, Inc. TVTX | Healthcare | United States | 3.30% | $15.58M |
| 15 | Ligand Pharmaceuticals Inc. LGND | Healthcare | United States | 3.19% | $15.09M |
| 16 | Regeneron Pharmaceuticals, Inc. REGN | Healthcare | United States | 3.14% | $14.84M |
| 17 | Harmony Biosciences Holdings, Inc. HRMY | Healthcare | United States | 3.06% | $14.46M |
| 18 | Bristol-Myers Squibb Co. BMY | Healthcare | United States | 2.94% | $13.89M |
| 19 | Viatris Inc. VTRS | Healthcare | United States | 2.82% | $13.33M |
| 20 | Jazz Pharmaceuticals PLC JAZZ | Healthcare | Ireland | 2.78% | $13.16M |
| 21 | Biogen Inc. BIIB | Healthcare | United States | 2.74% | $12.97M |
| 22 | Collegium Pharmaceutical, Inc. COLL | Healthcare | United States | 2.74% | $12.93M |
| 23 | Prestige Consumer Healthcare Inc. PBH | Healthcare | United States | 2.73% | $12.91M |
| 24 | Ocular Therapeutix, Inc. OCUL | Healthcare | United States | 2.57% | $12.17M |
| 25 | ANI Pharmaceuticals, Inc. ANIP | Healthcare | United States | 2.54% | $12.02M |